ATE471982T1 - Biologische variabilität von asthma-assoziiertem faktor 2 aaf2 (il-9 rezeptor) nützlich für die behandlung und diagnose von atopischen allergien wie asthma und asthma-ähnlichen erkrankungen - Google Patents

Biologische variabilität von asthma-assoziiertem faktor 2 aaf2 (il-9 rezeptor) nützlich für die behandlung und diagnose von atopischen allergien wie asthma und asthma-ähnlichen erkrankungen

Info

Publication number
ATE471982T1
ATE471982T1 AT04013403T AT04013403T ATE471982T1 AT E471982 T1 ATE471982 T1 AT E471982T1 AT 04013403 T AT04013403 T AT 04013403T AT 04013403 T AT04013403 T AT 04013403T AT E471982 T1 ATE471982 T1 AT E471982T1
Authority
AT
Austria
Prior art keywords
asthma
aaf2
diagnosis
treatment
atopic
Prior art date
Application number
AT04013403T
Other languages
German (de)
English (en)
Inventor
Roy Levitt
Luigi Grasso
Nicholas Nicolaides
Original Assignee
Genaera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaera Corp filed Critical Genaera Corp
Application granted granted Critical
Publication of ATE471982T1 publication Critical patent/ATE471982T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04013403T 1996-12-02 1997-12-02 Biologische variabilität von asthma-assoziiertem faktor 2 aaf2 (il-9 rezeptor) nützlich für die behandlung und diagnose von atopischen allergien wie asthma und asthma-ähnlichen erkrankungen ATE471982T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3222496P 1996-12-02 1996-12-02
US98087297A 1997-12-01 1997-12-01

Publications (1)

Publication Number Publication Date
ATE471982T1 true ATE471982T1 (de) 2010-07-15

Family

ID=26708147

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04013403T ATE471982T1 (de) 1996-12-02 1997-12-02 Biologische variabilität von asthma-assoziiertem faktor 2 aaf2 (il-9 rezeptor) nützlich für die behandlung und diagnose von atopischen allergien wie asthma und asthma-ähnlichen erkrankungen

Country Status (8)

Country Link
EP (1) EP0942979A2 (fr)
JP (2) JP4552076B2 (fr)
AT (1) ATE471982T1 (fr)
AU (1) AU746595B2 (fr)
CA (1) CA2271952C (fr)
DE (1) DE69739920D1 (fr)
ES (1) ES2347962T3 (fr)
PT (1) PT1471144E (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1632248T3 (da) * 1995-08-24 2011-01-24 Ligand Pharm Inc Anti-interleukin-9-antistof eller anti-interleukin-9-receptor-antistof til behandling af bronkial overfølsomhed

Also Published As

Publication number Publication date
JP4552076B2 (ja) 2010-09-29
JP2002514911A (ja) 2002-05-21
PT1471144E (pt) 2010-08-17
CA2271952C (fr) 2010-04-06
AU746595B2 (en) 2002-05-02
JP2009159976A (ja) 2009-07-23
EP0942979A2 (fr) 1999-09-22
AU5689198A (en) 1998-06-29
CA2271952A1 (fr) 1998-06-11
ES2347962T3 (es) 2010-11-26
DE69739920D1 (de) 2010-08-05

Similar Documents

Publication Publication Date Title
Gleichman et al. Glia in neurodegeneration: Drivers of disease or along for the ride?
Sun et al. Distinct profiles of REST interactions with its target genes at different stages of neuronal development
US9952216B2 (en) Brain-specific enhancers for cell-based therapy
DE69117949D1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
EP0750672A1 (fr) Sequences d'adn pour metalloproteases matricielles, leur production et leur utilisation
Mukherjee-Clavin et al. Comparison of three congruent patient-specific cell types for the modelling of a human genetic Schwann-cell disorder
WO1998024904A3 (fr) Variants de recepteur il-9, utilises pour le traitement et le diagnostic des allergies atopique, y compris l'asthme et les troubles apparentes
DE19805633A1 (de) Neue Serinprotease aus der Prostata
Qian et al. Identification of a new mutant allele, Grm6nob7, for complete congenital stationary night blindness
ATE471982T1 (de) Biologische variabilität von asthma-assoziiertem faktor 2 aaf2 (il-9 rezeptor) nützlich für die behandlung und diagnose von atopischen allergien wie asthma und asthma-ähnlichen erkrankungen
ATE398141T1 (de) Gegen den marburg i polymorphismus der faktor vii aktivierenden protease (fsap) gerichtete antikörper, ihre herstellung und verwendung
DE60037126D1 (de) POLYMORPHISMEN DES MENSCHLICHEN HPXR Gens UND IHRE ANWENDUNG IN DIAGNOSE UND THERAPIE
ATE517629T1 (de) Verwendung eines proteins der crmp familie zur behandlung von krankheiten des immunsystems
Miller et al. Humanin variant P3S is associated with longevity in APOE4 carriers and resists APOE4‐induced brain pathology
Gaastra et al. The amino‐acid sequence of kangaroo pancreatic ribonuclease
EP1709202A1 (fr) Mutation en a141s et g399s dans la proteine omi/htra2 dans la maladie de parkinson
DE60143608D1 (de) Neueskollagen-ähnliches protein clac, dessen vorläufer und dafür kodierende gene
CN107058254A (zh) 阿尔茨海默病新致病基因及其医药用途
Ooka et al. Characterization of side population (SP) cells in murine cochlear nucleus
HUP0100674A2 (hu) Mutáns prepo-neuropeptid-Y-t kódoló DNS-molekula, mutáns szignálpeptid és alkalmazásuk
Agoston et al. Complexity of transcriptional control in neuropeptide gene expression; enkephalin gene regulation during neurodevelopment
DK1429600T3 (da) En hvirvellös dyremodel med Alzheimerlignende patologi til at screene og teste molekyler
WO2003087332A3 (fr) Nouveaux polynucleotides codant le polypeptide kinase citron humain, bmsnkc 0020/0021
Mateusz et al. β-catenin signaling via astrocyte-encoded TCF7L2 regulates neuronal excitability and social behavior
Magrinelli et al. Diagnostic methods and emerging treatments for adult neuronal ceroid lipofuscinoses (Kufs disease)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties